Literature DB >> 1347939

The stimulants.

T E Wilens1, J Biederman.   

Abstract

Stimulants are the most commonly prescribed psychotropic medications in child psychiatry, used generally for the treatment of attention deficit hyperactivity disorder (ADHD). In this article, the authors summarize the literature on the prevalence of use, neurobiology, and pharmacology of stimulants. Likewise, recent studies on the use of stimulants are reviewed, such as their use in specific ADHD populations including those with conduct disorder, girls, preschoolers, adolescents, and adults. Clinical guidelines for the management of children and adolescents receiving stimulants are offered, and treatment strategies are delineated for ADHD subjects with comorbidity and medication-induced adverse effects.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1347939

Source DB:  PubMed          Journal:  Psychiatr Clin North Am        ISSN: 0193-953X


  25 in total

1.  The ritalin wars continue.

Authors:  L H Diller
Journal:  West J Med       Date:  2000-12

2.  Dopamine D4 receptors modulate brain metabolic activity in the prefrontal cortex and cerebellum at rest and in response to methylphenidate.

Authors:  Michael Michaelides; Javier Pascau; Juan-Domingo Gispert; Foteini Delis; David K Grandy; Gene-Jack Wang; Manuel Desco; Marcelo Rubinstein; Nora D Volkow; Panayotis K Thanos
Journal:  Eur J Neurosci       Date:  2010-07-16       Impact factor: 3.386

3.  Temporal relationships between the pharmacokinetics of methylphenidate in the human brain and its behavioral and cardiovascular effects.

Authors:  N D Volkow; G J Wang; S J Gatley; J S Fowler; Y S Ding; J Logan; R Hitzemann; B Angrist; J Lieberman
Journal:  Psychopharmacology (Berl)       Date:  1996-01       Impact factor: 4.530

Review 4.  Safety issues in the use of methylphenidate. An American perspective.

Authors:  M D Rappley
Journal:  Drug Saf       Date:  1997-09       Impact factor: 5.606

5.  Reboxetine versus methylphenidate in treatment of children and adolescents with attention deficit-hyperactivity disorder.

Authors:  Fariba Arabgol; Leily Panaghi; Paria Hebrani
Journal:  Eur Child Adolesc Psychiatry       Date:  2008-06-18       Impact factor: 4.785

6.  Methylphenidate treatment leads to abnormalities on krebs cycle enzymes in the brain of young and adult rats.

Authors:  Gislaine Z Réus; Giselli Scaini; Camila B Furlanetto; Meline O S Morais; Isabela C Jeremias; Lis Mairá Mello-Santos; Karolina V Freitas; João Quevedo; Emilio L Streck
Journal:  Neurotox Res       Date:  2013-02-20       Impact factor: 3.911

7.  Efficacy and safety of Ritalin LA, a new, once daily, extended-release dosage form of methylphenidate, in children with attention deficit hyperactivity disorder.

Authors:  Joseph Biederman; Declan Quinn; Margaret Weiss; Sabri Markabi; Meredith Weidenman; Kathryn Edson; Goeril Karlsson; Harald Pohlmann; Sharon Wigal
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

8.  Does switching from oral extended-release methylphenidate to the methylphenidate transdermal system affect health-related quality-of-life and medication satisfaction for children with attention-deficit/hyperactivity disorder?

Authors:  Oscar G Bukstein; L Eugene Arnold; Jeanne M Landgraf; Paul Hodgkins
Journal:  Child Adolesc Psychiatry Ment Health       Date:  2009-12-10       Impact factor: 3.033

9.  Methylphenidate improves motor functions in children diagnosed with Hyperkinetic Disorder.

Authors:  Liv Larsen Stray; Torstein Stray; Synnøve Iversen; Anne Ruud; Bjørn Ellertsen
Journal:  Behav Brain Funct       Date:  2009-05-13       Impact factor: 3.759

10.  Variability of response time as a predictor of methylphenidate treatment response in korean children with attention deficit hyperactivity disorder.

Authors:  Seung-Hye Lee; Dong-Ho Song; Bung-Nyun Kim; Yoo Sook Joung; Eun Hye Ha; Keun-Ah Cheon; Yee-Jin Shin; Hee Jeong Yoo; Dong-Won Shin
Journal:  Yonsei Med J       Date:  2009-10-21       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.